Insider Buying: Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Buys 276,040 Shares of Stock

Oscar Health, Inc. (NYSE:OSCR) Vice Chairman Joshua Kushner purchased 276,040 shares of Oscar Health stock in a transaction that occurred on Monday, November 11th. The shares were purchased at an average price of $13.58 per share, for a total transaction of $3,748,623.20. Following the transaction, the insider now directly owns 5,031,262 shares in the company, valued at $68,324,537.96. This represents a 5.80 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Joshua Kushner also recently made the following trade(s):

• On Wednesday, November 13th, Joshua Kushner bought 358,619 shares of Oscar Health stock. The shares were acquired at an average price of $13.74 per share, with a total value of $4,927,425.06.

Oscar Health Stock Performance

Oscar Health stock opened at $15.45 on Friday. The business has a 50 day moving average of $18.28 and a 200-day moving average of $18.30. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.91. Oscar Health, Inc. has a 1 year low of $6.93 and a 1 year high of $23.79. The company has a market capitalization of $3.74 billion, a P/E ratio of -251.12, a P/E/G ratio of 12.49 and a beta of 1.67.

Oscar Health (NYSE:OSCR) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.22) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.20) by ($0.02). Oscar Health had a net margin of 0.35% and a return on equity of 2.79%. The business had revenue of $2.42 billion for the quarter, compared to the consensus estimate of $2.33 billion. During the same period in the previous year, the business posted ($0.29) EPS. Oscar Health’s revenue was up 68.3% on a year-over-year basis. On average, equities research analysts predict that Oscar Health, Inc. will post -0.01 earnings per share for the current year.

Institutional Investors Weigh In On Oscar Health

A number of institutional investors have recently made changes to their positions in the stock. Quantbot Technologies LP boosted its holdings in Oscar Health by 435.5% in the first quarter. Quantbot Technologies LP now owns 14,495 shares of the company’s stock valued at $216,000 after acquiring an additional 11,788 shares during the last quarter. Oppenheimer & Co. Inc. increased its position in shares of Oscar Health by 20.8% during the first quarter. Oppenheimer & Co. Inc. now owns 19,450 shares of the company’s stock worth $289,000 after buying an additional 3,350 shares during the period. Swiss National Bank raised its stake in Oscar Health by 2.4% during the first quarter. Swiss National Bank now owns 263,800 shares of the company’s stock worth $3,923,000 after buying an additional 6,100 shares during the last quarter. Sei Investments Co. lifted its holdings in Oscar Health by 100.0% in the first quarter. Sei Investments Co. now owns 42,998 shares of the company’s stock valued at $639,000 after buying an additional 21,497 shares during the period. Finally, ProShare Advisors LLC boosted its position in Oscar Health by 10.9% during the first quarter. ProShare Advisors LLC now owns 28,950 shares of the company’s stock valued at $430,000 after acquiring an additional 2,842 shares during the last quarter. Institutional investors own 75.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on OSCR shares. Piper Sandler reissued an “overweight” rating and set a $28.00 price target on shares of Oscar Health in a report on Tuesday, September 10th. Bank of America cut Oscar Health from a “neutral” rating to an “underperform” rating and decreased their target price for the company from $21.00 to $13.50 in a research report on Wednesday, November 6th. Finally, UBS Group initiated coverage on shares of Oscar Health in a report on Monday, October 7th. They issued a “neutral” rating and a $23.00 target price for the company. One investment analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $22.93.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.